Toceranib phosphate-associated nephrotic syndrome in a dog: a case report.
Shannon M RemerowskiChamisa L HerreraLindsay L DonnellyPublished in: BMC veterinary research (2021)
Nephrotic syndrome is a potential adverse event associated with the drug toceranib phosphate which may be reversible with discontinuation of treatment. Careful monitoring of urine protein, serum biochemistry, blood pressure and patient weight is advisable during treatment with toceranib phosphate.